Publicacións nas que colabora con Francisco Gude Sampedro (42)

2023

  1. A clinician-to-clinician universal electronic consultation programme at the cardiology department of a Galician healthcare area improves healthcare accessibility and outcomes in elderly patients

    European Heart Journal - Digital Health, Vol. 4, Núm. 2, pp. 90-98

  2. Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation

    International Journal of Molecular Sciences, Vol. 24, Núm. 18

  3. The impact of inter-clinician electronic consultation in patients diagnosed with atrial fibrillation in primary care

    European Journal of Clinical Investigation, Vol. 53, Núm. 3

2022

  1. Early angiography in elderly patients with non-ST-segment elevation acute coronary syndrome: The cardio CHUS-HUSJ registry

    International Journal of Cardiology, Vol. 351, pp. 8-14

  2. Longer-Term Results of a Universal Electronic Consultation Program at the Cardiology Department of a Galician Healthcare Area

    Circulation. Cardiovascular quality and outcomes, Vol. 15, Núm. 1, pp. e008130

  3. Should PRECISE-DAPT be included for long-term prognostic stratification of diabetic patients with NSTEACS?

    Acta Diabetologica, Vol. 59, Núm. 2, pp. 163-170

2021

  1. Long-term cardiac reverse remodeling after cardiac resynchronization therapy

    Journal of Arrhythmia, Vol. 37, Núm. 3, pp. 653-659

  2. Prognostic benefit from an early invasive strategy in patients with non-ST elevation acute coronary syndrome (NSTEACS): evaluation of the new risk stratification in the NSTEACS European guidelines

    Clinical Research in Cardiology, Vol. 110, Núm. 9, pp. 1464-1472

  3. Prognostic impact of left ventricular ejection fraction recovery in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: Analysis of an 11-year all-comers registry

    European Heart Journal: Acute Cardiovascular Care, Vol. 10, Núm. 8, pp. 898-908

  4. Removal of the intermediate risk group in the latest European guidelines for NSTEACS: is it justified?

    Revista Espanola de Cardiologia, Vol. 74, Núm. 10, pp. 891-893

2020

  1. Development and validation of a clinical score to estimate progression to severe or critical state in COVID-19 pneumonia hospitalized patients

    Scientific Reports, Vol. 10, Núm. 1

  2. Early revascularization and long-term mortality in high-risk patients with non–ST-elevation myocardial infarction. The CARDIOCHUS-HUSJ registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 35-42

  3. Prediction of major adverse cardiac, cerebrovascular events in patients with diabetes after acute coronary syndrome

    Diabetes and Vascular Disease Research, Vol. 17, Núm. 1

2019

  1. Targeting relatives: Impact of a cardiac rehabilitation programme including basic life support training on their skills and attitudes

    European Journal of Preventive Cardiology, Vol. 26, Núm. 8, pp. 795-805

2018

  1. Cardiac resynchronization therapy outcomes in patients under nonoptimal medical therapy

    Journal of Arrhythmia, Vol. 34, Núm. 5, pp. 548-555

  2. Cardiac resynchronization therapy response in heart failure patients with different subtypes of true left bundle branch block

    Journal of Interventional Cardiac Electrophysiology, Vol. 52, Núm. 1, pp. 91-101

  3. Prognostic value of nutrition status in the response of cardiac resynchronization therapy

    Indian Pacing and Electrophysiology Journal, Vol. 18, Núm. 4, pp. 133-139

  4. Temporal trends between association of evidence-based treatment and outcomes in patients with non-ST-elevation myocardial infarction

    International Journal of Cardiology, Vol. 260, pp. 1-6

2016

  1. Is HATCH score a reliable predictor of atrial fibrillation after cavotricuspid isthmus ablation for typical atrial flutter?

    IJC Heart and Vasculature, Vol. 12, pp. 88-94

  2. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis

    QJM, Vol. 109, Núm. 6, pp. 377-382